Affinia Therapeutics

WALTHAM, Mass., April 28, 2026 Affinia Therapeutics has announced new progress for AFTX-201, its lead investigational gene therapy for...

Waltham, Massachusetts, USA, April 6, 2026 Health Canada Approval Marks Key Clinical Milestone In a significant development for cardiovascular...